Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study.
about
Vaccines for preventing pneumococcal infection in adultsInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseVaccines for preventing pneumococcal infection in adultsInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseAre the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trialsEffect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysisInfluenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based reviewPneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Efficacy of pneumococcal vaccination in adults: a meta-analysis.Chronic obstructive pulmonary disease . 7: Management of COPDCost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia.Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study.Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation.Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future.Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.Epidemiology of community- and nursing home-acquired pneumonia in older adults.Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.Prevention in family practice: Consensus statement from the front line.Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.Clinical effectiveness of pneumococcal vaccine. Meta-analysis.Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.Pneumococcal polysaccharide vaccine: cost-effectiveness recommendations in adults.Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases?Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease.Risk Factors for Pneumonia and the Effect of the Pneumococcal Vaccine in Patients With Chronic Airflow Obstruction.
P2860
Q24201474-DA91B464-BB67-43D3-AB85-1B7A3623DDD7Q24236699-BDCDCFD4-2133-4372-8D93-9B97FE417A67Q24242290-E64D28A7-D3A0-4B62-85AF-9F7A33DF533AQ24243866-BD4834CD-9180-4809-B2C6-F0496D39951DQ24795536-B3E22A53-7845-40C2-81CB-1F923C71A91BQ26801433-6D286701-513B-4A10-9388-D0BF46CA1148Q27007003-4ABDF7BB-C12C-45CF-899B-7253D2101722Q28070059-FA719D29-7B86-4B96-8FA6-F0CFC4A226D0Q30238816-46BFB1B5-2AC2-4B12-8644-01E8E49D3084Q34657877-A89637DA-E029-4205-B21C-3F0D6AC2AA33Q35075588-BD8D4F28-A856-4A2B-8696-904836DAEA01Q35134469-4422B9E1-0051-4029-8504-A0AB904A79BCQ35319990-DEF8D1E3-72DA-4E1D-9E5B-7A642BDD1340Q35520406-B14957D5-4571-4721-BBBA-FD6C3BCDB8E5Q35574022-C9B30725-C2A4-4136-A6E4-182CE66A4F14Q35636112-04D23472-6879-4B00-AD36-5948FF6804A1Q36140683-BC401805-D157-456A-B730-3AF7F4C5CC11Q36257961-D915BB30-DE00-4BCD-A25A-201D4D5FF3D0Q36283924-D1D08429-FE5E-4B11-883E-7900ECFC4C4BQ36379580-083699D2-19B5-425A-A23C-E612FCA3CACBQ36578027-F5D9E1D7-735E-44CF-8D98-2B6F7727B98CQ37224498-8D85DB23-5BD2-4221-8B94-5717B6AFB9C7Q37343744-92B264D6-5195-44BD-BBE7-9118EDC9863DQ37609401-D0262EB1-AD0B-43CB-8FBA-7C51FA8CF0B5Q37981768-572694A6-9E75-4C3B-88ED-1BB644E4A1FAQ39872559-5A18D3E4-03D1-4109-B2F4-CF60C2C4BAC1Q40469947-7D322DAC-A62C-4935-A1BB-D0C7EEC48DD8Q41398172-C59C4AA2-0B41-41E5-B0FF-8A6AC8CEE080
P2860
Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Pneumococcal infection and imm ...... monary disease. A pilot study.
@en
Pneumococcal infection and imm ...... monary disease. A pilot study.
@nl
type
label
Pneumococcal infection and imm ...... monary disease. A pilot study.
@en
Pneumococcal infection and imm ...... monary disease. A pilot study.
@nl
prefLabel
Pneumococcal infection and imm ...... monary disease. A pilot study.
@en
Pneumococcal infection and imm ...... monary disease. A pilot study.
@nl
P2093
P356
P1433
P1476
Pneumococcal infection and imm ...... monary disease. A pilot study.
@en
P2093
Christianson LC
Schiffman G
P304
P356
10.1378/CHEST.92.2.204
P407
P577
1987-08-01T00:00:00Z